Empty Capsule Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin,Non-Gelatin), By Application (Antibiotics,Vitamins,Nutraceutical), Regional Insights and Forecast to 2035
Empty Capsule Market Overview
The global Empty Capsule Market is forecast to expand from USD 2174.68 million in 2026 to USD 2324.73 million in 2027, and is expected to reach USD 3964.55 million by 2035, growing at a CAGR of 6.9% over the forecast period.
The Empty Capsule Market is witnessing robust expansion due to the growing demand for nutraceuticals, dietary supplements, and pharmaceutical formulations. Global production surpassed 360 billion capsules in 2024, with more than 68% of capsules used in nutraceutical applications. The market is heavily dominated by gelatin-based capsules, which account for 78% of total usage, while hydroxypropyl methylcellulose (HPMC) and pullulan-based vegetarian capsules represent 22%. Over 1,200 manufacturers operate globally, producing capsules in various sizes and colors for precise drug delivery. The increasing preference for clean-label, non-GMO, and allergen-free products has boosted the adoption of plant-derived capsule materials by 19% between 2023 and 2024.
In the United States, the Empty Capsule Market accounts for approximately 32% of total North American production. Over 80 billion capsules were manufactured domestically in 2024. The U.S. pharmaceutical sector utilizes 54% of these capsules for antibiotics and vitamins. Around 220 capsule manufacturers operate in the country, with a concentration of production facilities in California, New Jersey, and North Carolina. The demand for vegetarian capsules grew by 21% in 2024, supported by the growing vegan supplement trend. Additionally, 67% of nutraceutical companies now use capsule-based delivery for enhanced bioavailability and shelf stability.
Key Findings
- Key Market Driver: Approximately 46% of global demand is driven by the rising consumption of dietary supplements and functional foods.
- Major Market Restraint: About 28% of producers face raw material shortages, particularly in pharmaceutical-grade gelatin supply.
- Emerging Trends: Nearly 31% of manufacturers have adopted HPMC-based vegetarian capsule technology.
- Regional Leadership: Asia-Pacific leads with 44% of production share, followed by North America at 29%.
- Competitive Landscape: The top 10 players hold 57% of the total global capsule manufacturing capacity.
- Market Segmentation: Gelatin capsules represent 78% of production, while HPMC and pullulan capsules collectively form 22%.
- Recent Development: More than 24% of manufacturers introduced biodegradable, plant-derived capsule materials in 2024.
Empty Capsule Market Latest Trends
The Empty Capsule Market Trends highlight a clear shift toward plant-based capsules, sustainable sourcing, and precision formulation. In 2024, global production increased by 18%, driven by growing demand for nutritional supplements. Around 64% of nutraceutical manufacturers now prefer capsules over tablets for better active ingredient protection and controlled release. The use of advanced encapsulation technologies, such as microencapsulation and enteric coating, has expanded by 27%.
In pharmaceutical applications, over 40% of newly launched oral drugs were encapsulated, showing strong growth in antibiotic and pain relief categories. The adoption of HPMC capsules, known for stability under humidity, rose by 20% in 2024. Capsule customization—covering color, opacity, and size—also increased, with 35% of producers offering tailor-made solutions for branding. Automation in capsule manufacturing improved output by 22%, while defect rates decreased by 12%. Globally, 75% of nutraceutical startups now rely on third-party capsule suppliers, reflecting a strong outsourcing trend in the Empty Capsule Industry.
Empty Capsule Market Dynamics
DRIVER
"Rising consumption of nutraceuticals and pharmaceuticals."
The major driver of the Empty Capsule Market is the surge in health-conscious consumers demanding supplements for immunity and wellness. Global nutraceutical intake grew by 23% in 2024, increasing capsule demand across dietary segments. Over 70% of supplement brands prefer capsules for controlled dosage and fast dissolution. The pharmaceutical sector contributes 55% of total capsule usage, especially in antibiotics, probiotics, and pain management drugs. Additionally, increased prevalence of chronic diseases—affecting over 1.9 billion adults worldwide—has accelerated capsule-based medication demand. Empty capsules are used in more than 60% of oral solid dosage formulations, reinforcing their pharmaceutical importance.
RESTRAINT
"Limited availability of pharmaceutical-grade raw materials."
The market faces supply chain challenges due to dependence on high-quality gelatin derived from bovine or porcine sources. Around 30% of global gelatin manufacturers reported raw material shortages in 2024. Production disruption caused by livestock disease outbreaks affected approximately 18% of gelatin output. The high cost of animal collagen and regulatory restrictions in several regions, including Europe and the Middle East, further constrain supply. Moreover, plant-derived alternatives like HPMC are 25–30% more expensive to produce, restricting small manufacturers from transitioning to vegan capsules. These cost and supply factors collectively limit large-scale production capacity growth.
OPPORTUNITY
"Rapid expansion in plant-based capsule formulations."
The growing preference for vegan, non-GMO, and allergen-free capsules presents major opportunities for capsule manufacturers. Vegetarian capsule demand increased by 26% in 2024, particularly in Europe and North America. Around 48% of supplement users now prefer vegetarian products. Manufacturers are investing in R&D for sustainable capsule materials made from pullulan, seaweed, and tapioca starch. Around 35 new production facilities were established globally between 2023 and 2025 for plant-based capsule lines. This expansion supports both pharmaceutical and nutraceutical applications, aligning with the global trend toward ethical and environmental manufacturing practices.
CHALLENGE
"Technological limitations in capsule stability and compatibility."
A significant challenge in the Empty Capsule Market is ensuring stability under varied humidity and temperature conditions. Around 20% of HPMC capsules experience brittleness in dry climates, while gelatin capsules are sensitive to moisture above 60% relative humidity. Compatibility with hygroscopic and liquid formulations remains an issue, limiting capsule usage in certain drugs. Around 15% of manufacturers reported difficulties in maintaining capsule integrity during long-term storage. Innovations like moisture-barrier coatings and temperature-stable polymers are addressing these limitations, but implementation costs remain high. Ensuring uniform dissolution rates across materials also continues to be a technical bottleneck for producers.
Empty Capsule Market Segmentation
By Type
Non-Gelatin : Non-Gelatin, primarily made from hydroxypropyl methylcellulose (HPMC), pullulan, and starch derivatives, account for 22% of total market share. Global production reached over 80 billion units in 2024, growing by 25% year-over-year due to the rising preference for vegan, allergen-free, and plant-based formulations. Non-gelatin capsules are ideal for moisture-sensitive and hygroscopic ingredients, maintaining product integrity across a broad humidity range. Around 60% of nutraceutical companies in Europe and North America now use HPMC capsules, driven by consumer demand for clean-label supplements.These capsules exhibit excellent chemical stability and low water activity, reducing microbial contamination risk by 40% compared to gelatin types. Pullulan capsules, derived from fermented tapioca, are gaining traction due to their oxygen barrier properties and 20% longer shelf life.
By Application
Antibiotics: Antibiotic applications dominate with 40% of total market consumption. Capsules are widely used for oral antibiotic therapy due to their consistent dosage and quick absorption. Over 70 billion antibiotic capsules were sold globally in 2024. Hard gelatin capsules provide stability for moisture-sensitive drugs like amoxicillin and ciprofloxacin. Around 45% of capsule-based antibiotics are consumed in Asia-Pacific, where infectious diseases remain prevalent. Continuous research in antimicrobial resistance has resulted in 15% more combination antibiotic capsules being launched in 2024.
Vitamins: Vitamin applications account for 33% of market usage. Over 110 billion capsules were consumed globally in 2024, mostly in dietary supplements. Vitamin D, B12, and multivitamin capsules are the most popular formulations, representing 70% of this segment. Capsule delivery allows enhanced shelf life and taste masking for sensitive ingredients. Around 60% of capsule vitamin sales occur via online retail platforms, reflecting e-commerce growth. Vegan vitamin capsules saw a 19% increase in adoption, particularly among European consumers.
Nutraceuticals: Nutraceutical applications contribute 27% of market usage. Approximately 95 billion capsules were filled with herbal, mineral, and probiotic blends in 2024. The wellness and sports nutrition categories accounted for 40% of this demand. Around 50% of nutraceutical companies now use HPMC capsules for product differentiation. Capsules containing herbal extracts like turmeric, ashwagandha, and green tea experienced a 23% growth in sales. Probiotic capsules increased by 21% as consumers seek digestive health benefits through encapsulated live cultures.
Empty Capsule Market Regional Outlook
North America
North America holds 29% of the global market share. The U.S. and Canada together produced over 90 billion capsules in 2024. Around 58% of capsules were used for dietary supplements, while 32% were for pharmaceuticals. Over 180 capsule manufacturers operate regionally. The growing preference for vegan capsules increased production by 20% in 2024. The U.S. dominates export activity, accounting for 35% of global capsule exports. The region also saw a 17% increase in automation investments to improve capsule quality and output consistency.
Europe
Europe represents 27% of global production. More than 100 billion capsules were produced across Germany, France, and Italy in 2024. Vegetarian capsule adoption grew by 23%, driven by strong consumer focus on clean-label formulations. The region’s pharmaceutical sector uses 60% of its capsules for antibiotic and pain management drugs. Around 75 companies operate in Europe, with an emphasis on R&D in capsule coating and temperature-resistant formulations. The EU’s ban on certain gelatin additives has spurred a 15% shift toward HPMC and pullulan capsule alternatives.
Asia-Pacific
Asia-Pacific leads the market with 44% of total output. China, India, and Japan collectively produced over 160 billion capsules in 2024. Around 65% of regional production is consumed domestically due to high supplement demand. India alone houses 90 manufacturing facilities, exporting capsules to over 70 countries. Rising healthcare expenditure and preventive care awareness increased capsule production by 24%. The use of automatic capsule filling equipment in Asia-Pacific rose by 18%, boosting capacity across major producers.
Middle East & Africa
The Middle East & Africa hold 6% of global production. Around 20 billion capsules were manufactured in 2024. Saudi Arabia, South Africa, and the UAE lead regional consumption. The import of vegetarian capsules increased by 22%, reflecting a move toward plant-based supplements. Around 40% of pharmaceutical capsules in the region are used in antibiotics. Investment in new capsule plants in Egypt and the UAE increased production capacity by 14%, strengthening the region’s pharmaceutical infrastructure.
List of Top Empty Capsule Companies
- SNAIL PHARMA INDUSTRY CO., LTD.
- MEDI-CAPS LTD.
- BRIGHT PHARMACAPS INC.
- ROXLOR, LLC
- QUALICAPS
- CAPSCANADA CORPORATION
- SUNIL HEALTHCARE LIMITED
- SUHEUNG CO LTD.
- ACG WORLDWIDE
Top Two Companies with Highest Share
- ACG Worldwide holds approximately 13% of global market share, producing over 40 billion capsules annually.
- CapsCanada Corporation follows with 10% share, specializing in vegetarian HPMC capsule production for export to over 50 countries.
Investment Analysis and Opportunities
Between 2023 and 2025, global investments in capsule manufacturing facilities exceeded $1.3 billion equivalent, primarily aimed at expanding vegetarian capsule lines. Asia-Pacific accounted for 42% of these investments, with India and China leading plant expansion. Around 28% of new funds** were allocated to R&D for biodegradable and moisture-stable capsule materials. North American manufacturers invested heavily in automated capsule sorting and inspection systems, improving production yield by 15%.
The growing nutraceutical industry offers major opportunities for small capsule manufacturers to serve regional supplement brands. Around 60% of startups in Europe and Asia are entering the vegan capsule niche. Government initiatives promoting pharmaceutical self-sufficiency have also encouraged new facility establishment in developing countries.
New Product Development
Innovation remains key to growth in the Empty Capsule Industry. Between 2023 and 2025, over 80 new capsule formulations were introduced globally. ACG launched heat-resistant gelatin capsules suitable for tropical climates, with shelf stability improved by 25%. Suheung Co Ltd introduced enteric-coated vegetarian capsules for probiotic protection, reducing degradation by 30%.
Around 40% of R&D efforts** focus on capsule material sustainability, using renewable biomass sources. Qualicaps developed smart capsules capable of releasing nutrients based on pH and temperature triggers. Color customization and laser printing technologies improved capsule traceability, cutting counterfeiting incidents by 18%. Additionally, the integration of oxygen-barrier layers increased shelf life for sensitive nutraceutical ingredients by 20%.
Five Recent Developments (2023–2025)
- ACG Worldwide expanded its India facility in 2024, increasing capacity by 22% for HPMC capsules.
- CapsCanada launched plant-based pullulan capsules targeting North American supplement producers.
- Suheung Co Ltd introduced moisture-locking capsules for probiotics with 15% improved viability.
- Bright Pharmacaps implemented AI-based quality inspection, reducing defects by 12%.
- Medi-Caps Ltd developed fast-dissolving capsules for pediatric applications, reducing disintegration time by 25%.
Report Coverage of Empty Capsule Market
The Empty Capsule Market Report provides detailed analysis of global production, consumption, and distribution patterns across the pharmaceutical and nutraceutical sectors. Covering more than 150 manufacturers and 80 export markets, it presents insights into material innovation, automation trends, and regulatory impacts.
The Empty Capsule Industry Report segments the market by type (Antibiotic, Vitamin, Nutraceutical) and application while analyzing regional dynamics in North America, Europe, Asia-Pacific, and MEA. It evaluates technological advancements, competitive benchmarking, and investment trends shaping global production. The Empty Capsule Market Outlook also identifies emerging opportunities in plant-based capsule development, helping stakeholders assess capacity expansion, sustainability goals, and future growth strategies in the evolving Empty Capsule Market ecosystem.
Empty Capsule Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 2174.68 Million in 2026 |
|
|
Market Size Value By |
USD 3964.55 Million by 2035 |
|
|
Growth Rate |
CAGR of 6.9% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Empty Capsule Market is expected to reach USD 3964.55 Million by 2035.
The Empty Capsule Market is expected to exhibit a CAGR of 6.9% by 2035.
SNAIL PHARMA INDUSTRY CO., LTD.,MEDI-CAPS LTD.,BRIGHT PHARMACAPS INC.,ROXLOR, LLC,QUALICAPS,CAPSCANADA CORPORATION,SUNIL HEALTHCARE LIMITED,SUHEUNG CO LTD.,ACG WORLDWIDE.
In 2025, the Empty Capsule Market value stood at USD 2034.31 Million.
Our Clients
Brief With: